| Dr Nasar Ahmad Siddiqi, MD | |
|
1090 Medical Center Dr, Wilmington, NC 28401-7353 | |
| (910) 662-8550 | |
| (910) 343-1924 |
| Full Name | Dr Nasar Ahmad Siddiqi |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 15 Years |
| Location | 1090 Medical Center Dr, Wilmington, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336377639 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | LL31840 (South Carolina) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 201500286 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New Hanover Regional Medical Center | Wilmington, NC | Hospital |
| Novant Health Brunswick Medical Center | Supply, NC | Hospital |
| J Arthur Dosher Memorial Hospital | Southport, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Novant Health Medical Group Coastal Region Llc | 2860809936 | 412 |
News Archive
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has launched new education, distribution, sampling and reimbursement programs for TIMOPTIC(R) in OCUDOSE(R), the only preservative-free medication for glaucoma available in the United States. Aton acquired the U.S. marketing rights in February to the TIMOPTIC product line from Merck & Co., Inc. TIMOPTIC (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. As many as 2.25 million Americans suffer from open-angle glaucoma.
Barr Pharmaceuticals, Inc. has announced that U.S. District Court for Delaware has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Boehringer Ingelheim Pharmaceuticals, Inc. in connection with Boehringer Ingelheim's Mirapex(R) Tablets (pramipexole dihydrochloride) 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg.
Up to 70 per cent of Victorians with suspected hepatitis C may not have received follow-up testing, putting them at risk of chronic liver disease and even cancer, University of Melbourne researchers say.
While their friends enjoy the latest hit tunes, people who are tone deaf – in scientific terms, suffering from amusia – are excluded from the fun, unable to tell one note from another. The disorder can be congenital, present from birth, or acquired following injury to the brain.
› Verified 3 days ago
| Entity Name | Coastal Pulmonary Medicine Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851375794 PECOS PAC ID: 6608974431 Enrollment ID: O20070601000477 |
News Archive
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has launched new education, distribution, sampling and reimbursement programs for TIMOPTIC(R) in OCUDOSE(R), the only preservative-free medication for glaucoma available in the United States. Aton acquired the U.S. marketing rights in February to the TIMOPTIC product line from Merck & Co., Inc. TIMOPTIC (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. As many as 2.25 million Americans suffer from open-angle glaucoma.
Barr Pharmaceuticals, Inc. has announced that U.S. District Court for Delaware has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Boehringer Ingelheim Pharmaceuticals, Inc. in connection with Boehringer Ingelheim's Mirapex(R) Tablets (pramipexole dihydrochloride) 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg.
Up to 70 per cent of Victorians with suspected hepatitis C may not have received follow-up testing, putting them at risk of chronic liver disease and even cancer, University of Melbourne researchers say.
While their friends enjoy the latest hit tunes, people who are tone deaf – in scientific terms, suffering from amusia – are excluded from the fun, unable to tell one note from another. The disorder can be congenital, present from birth, or acquired following injury to the brain.
› Verified 3 days ago
| Entity Name | Novant Health Medical Group Coastal Region Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649865791 PECOS PAC ID: 2860809936 Enrollment ID: O20210408000285 |
News Archive
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has launched new education, distribution, sampling and reimbursement programs for TIMOPTIC(R) in OCUDOSE(R), the only preservative-free medication for glaucoma available in the United States. Aton acquired the U.S. marketing rights in February to the TIMOPTIC product line from Merck & Co., Inc. TIMOPTIC (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. As many as 2.25 million Americans suffer from open-angle glaucoma.
Barr Pharmaceuticals, Inc. has announced that U.S. District Court for Delaware has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Boehringer Ingelheim Pharmaceuticals, Inc. in connection with Boehringer Ingelheim's Mirapex(R) Tablets (pramipexole dihydrochloride) 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg.
Up to 70 per cent of Victorians with suspected hepatitis C may not have received follow-up testing, putting them at risk of chronic liver disease and even cancer, University of Melbourne researchers say.
While their friends enjoy the latest hit tunes, people who are tone deaf – in scientific terms, suffering from amusia – are excluded from the fun, unable to tell one note from another. The disorder can be congenital, present from birth, or acquired following injury to the brain.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nasar Ahmad Siddiqi, MD Po Box 936857, Atlanta, GA 31193-6857 Ph: () - | Dr Nasar Ahmad Siddiqi, MD 1090 Medical Center Dr, Wilmington, NC 28401-7353 Ph: (910) 662-8550 |
News Archive
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced it has launched new education, distribution, sampling and reimbursement programs for TIMOPTIC(R) in OCUDOSE(R), the only preservative-free medication for glaucoma available in the United States. Aton acquired the U.S. marketing rights in February to the TIMOPTIC product line from Merck & Co., Inc. TIMOPTIC (timolol maleate) is a non-selective beta-adrenergic receptor blocking agent indicated for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. As many as 2.25 million Americans suffer from open-angle glaucoma.
Barr Pharmaceuticals, Inc. has announced that U.S. District Court for Delaware has ruled in favor of its subsidiary, Barr Laboratories, Inc., in the challenge of the patent listed by Boehringer Ingelheim Pharmaceuticals, Inc. in connection with Boehringer Ingelheim's Mirapex(R) Tablets (pramipexole dihydrochloride) 0.125mg, 0.25mg, 0.5mg, 1mg & 1.5mg.
Up to 70 per cent of Victorians with suspected hepatitis C may not have received follow-up testing, putting them at risk of chronic liver disease and even cancer, University of Melbourne researchers say.
While their friends enjoy the latest hit tunes, people who are tone deaf – in scientific terms, suffering from amusia – are excluded from the fun, unable to tell one note from another. The disorder can be congenital, present from birth, or acquired following injury to the brain.
› Verified 3 days ago
Dr. James Carden Mccabe, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1302 Medical Center Dr, Wilmington, NC 28401 Phone: 910-343-9800 Fax: 910-343-9800 | |
Michael Mundy Ward, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2215 Canterwood Dr, Wilmington, NC 28401 Phone: 910-762-4600 Fax: 910-762-9483 | |
Latessa Spiers, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1960 S 16th St, Wilmington, NC 28401 Phone: 910-343-9991 | |
Dr. Kavita S Persaud, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5919 Oleander Dr Ste 109, Wilmington, NC 28403 Phone: 910-799-5508 Fax: 910-202-0654 | |
Dr. Regina Marie Jensen, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 4536 Technology Dr, Ste 3, Wilmington, NC 28405 Phone: 910-343-8411 Fax: 910-343-8414 | |
Mary Kathryn Rudyk, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1709 S 16th St Ste A, Wilmington, NC 28401 Phone: 910-452-8633 Fax: 910-452-8569 | |
Gregory Roberts, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1202 Medical Center Dr, Wilmington, NC 28401 Phone: 910-341-3300 Fax: 910-341-7946 |